Finance

Lists
6OP:FRA
Ose Immunotherapeutics SA
2,08 €
+0,77%
(+0,016) 1D
9 қаз., 08:01:35 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6OP...
Open
2,08 €
High
2,08 €
Low
2,08 €
Mkt. cap
50,32 млн
Avg. vol.
47,00
Volume
0,00
52-wk high
6,95 €
52-wk low
2,03 €
EPS
-1,69 €
No. of employees
64
Open
2,08 €
High
2,08 €
Low
2,08 €
Mkt. cap
50,32 млн
Avg. vol.
47,00
Volume
0,00
52-wk high
6,95 €
52-wk low
2,03 €
EPS
-1,69 €
No. of employees
64
News stories
From web sources and news partners
About Ose Immunotherapeutics SA
CEO-
Employees64
Founded2004 ж. 17 қар.
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2024 ж. қыр.
2024 ж. жел.
Revenue
431,00 м.
431,00 м.
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
8,28 млн
8,28 млн
Total research and development expenses
-
-
Selling, general, and admin expenses
1,08 млн
1,08 млн
Operating expense
10,22 млн
10,22 млн
Total operating expenses
10,22 млн
10,22 млн
Operating income
-9,79 млн
-9,79 млн
Other non operating income
-611,00 м.
-611,00 м.
EBT including unusual items
-10,44 млн
-10,44 млн
EBT excluding unusual items
-10,53 млн
-10,53 млн
Income tax expense
-576,50 м.
-576,50 м.
Effective tax rate
5,52%
5,52%
Other operating expenses
41,00 мың
41,00 мың
Net income
-9,86 млн
-9,86 млн
Net profit margin
-2 288,86%
-2 288,86%
Earnings per share
-
-
Interest and investment income
571,00 м.
571,00 м.
Interest expense
-707,50 м.
-707,50 м.
Net interest expenses
-136,50 м.
-136,50 м.
Depreciation and amortization charges
-
-
EBITDA
-9,74 млн
-9,74 млн
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
Google қолданбалары